SS
MIST icon

Steve Schonfeld’s Milestone Pharmaceuticals MIST Stock Holding History

Steve Schonfeld’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-146,806
Closed -$578K – 2361
2023
Q1 		$578K Buy
146,806
+65,821
+81% +$241K 0.01% 1125
2022
Q4 		$321K Buy
+80,985
New +$426K ﹤0.01% 1758
2020
Q3 		– Sell
-33,200
Closed -$125K – 1537
2020
Q2 		$125K Buy
+33,200
New +$107K ﹤0.01% 1159

Other funds holding MIST

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Steve Schonfeld's MIST Position: Q2 2023 in Review

Steve Schonfeld sold out of Milestone Pharmaceuticals (MIST) in Q2 2023, closing a stake of 146,806 shares — an estimated $578K sold.

Steve Schonfeld first reported a position in MIST in Q2 2020 and held it in 3 quarters. The position peaked at $578K in Q1 2023. 48 funds tracked by Wall St. Rank hold MIST as of Q2 2023.

  • Steve Schonfeld reported no remaining Milestone Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Steve Schonfeld sold 146,806 Milestone Pharmaceuticals shares in Q2 2023, an estimated $578K.
  • Steve Schonfeld first reported a position in Milestone Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Steve Schonfeld's Milestone Pharmaceuticals position peaked at $578K in Q1 2023.
  • 48 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.